View of Nirsevimab: a change of paradigm in the prophylaxis of Respiratory Syncytial Virus disease among infants

Return to Article Details Nirsevimab: a change of paradigm in the prophylaxis of Respiratory Syncytial Virus disease among infants Download Download PDF